Open access research
ALETH / ABOUT
Aleth is an open-access research platform focused on scientific innovation across life sciences, artificial intelligence and deep tech, particularly quantum technologies and robotics.
Our focus is global, with a UK tilt, and extends across private and public markets. These are the parts of the economy where many of the most important technologies are emerging, but where the companies developing them are often difficult to find, understand and value.
Aleth was founded by Stef Hamill. Stef spent his career as a top-ranked equity analyst, co-founding Clear Capital, a research boutique that was later acquired, and holds a CFA and PhD in protein folding from Cambridge. He now works with technology companies and investors across private and public markets.
Aleth is built AI-native with rigorous human oversight. The aim is not to automate judgement. It is to automate the work required to bring the right evidence, in the right form, to the person responsible for making that judgement.
This site will hold our research archive, while new research is delivered directly by email. Subscribe free via Substack (opens in new tab) to receive our latest life sciences, AI and deep tech analysis as it is published.
Nothing published by Aleth is investment advice.
* * *
ALETH / RESEARCH IS KEY TO ECONOMIC GROWTH
As an analyst I viewed myself as a small cog in a large machine: there to improve the efficiency of capital markets.
Good research helps capital find good companies. It allows investors to understand unfamiliar technologies, compare opportunities and distinguish genuine progress from a persuasive story. Better information improves price discovery, lowers uncertainty and makes it easier for companies with sound fundamentals to attract capital.
The machine is no longer working as well as it should.
Research coverage has become concentrated on the largest and most liquid public companies. Smaller listed companies receive less attention, while most private companies receive little independent scrutiny at all. These are often the companies where scientific and technical innovation is happening.
The result is a widening information gap. Promising companies can remain undiscovered or misunderstood. Investors struggle to build sufficient knowledge to participate. Markets become less liquid, the cost of capital rises and funding flows towards the opportunities that are easiest to understand rather than necessarily those with the greatest potential.
These distortions filter through the real economy, slowing the movement of capital into productive innovation and ultimately reducing economic growth.
ALETH / THE OPPORTUNITY IS DIFFICULT TO SEE
In technology-driven sectors, the research problem begins before conventional company analysis.
The relevant universe is rarely complete or clearly defined. Important science may be emerging from an academic laboratory. A company may still be private, operating quietly or known only within a specialist network. A significant change may first appear in a scientific paper, patent, clinical record, grant award, financing announcement, regulatory filing or new partnership.
Finding the opportunity is therefore part of the research.
Aleth aims to map emerging technologies, companies and corporate activity across life sciences, AI and deep tech. This means following both the development of promising science and the companies forming around it, from university spin-outs and venture-backed businesses through to established public companies.
Public-market research usually begins with a known company and a regular flow of financial information. Private-market research is less orderly. The evidence is fragmented, disclosure is limited and financial measures are inconsistent. Understanding the company may require reconstructing its development from many different sources.
This is where scientific and technical judgement matters. The task is not simply to collect more information, but to understand what a technology does, what has genuinely changed, what evidence would validate it and where commercial value might ultimately accrue.
ALETH / RESEARCH IS BECOMING AUTOMATED
The traditional analyst role combines judgement with a large amount of manual production work.
Analysts search for disclosures, collect data, update spreadsheets, maintain financial models, compare new information with history, build charts and tables and turn the results into written research. Much of this work has always been necessary. Much of it will not remain manual.
The direction of travel is clear. An increasing proportion of research production will be automated.
Systems will identify relevant developments, extract and structure information, maintain company histories, update models, compare evidence and prepare initial analysis. Financial models will become living research objects that can be interrogated, changed and stress-tested through natural language rather than manually rebuilt each time a question changes.
This does not make human judgement less important. It makes judgement more visible.
Value will increasingly reside in deciding which questions matter, determining whether the available evidence is sufficient, identifying what the market has misunderstood and accepting responsibility for the conclusion. The analyst of the future should spend less time moving information and more time thinking about it.
Aleth aims to be part of that transition.
ALETH / WHAT WE ARE BUILDING
Aleth is building research infrastructure for discovering, understanding and evaluating technology-driven companies.
Our first products are the Aleth Briefs. They reconstruct the important developments in each field from their underlying sources, filtering out duplicated reporting and giving readers a direct route back to the evidence. Their immediate purpose is simple: to reduce the time required to remain properly informed.
Each Brief also adds to a growing research corpus.
As the archive develops, Aleth accumulates a structured history of companies, technologies, financings, partnerships, regulatory events and scientific developments. Each new issue expands that knowledge base, improves the underlying research process and provides additional context for interpreting what happens next.
This should allow Aleth to move beyond individual news events towards identifying the trends and themes that emerge across them: where activity is accelerating, which technologies are approaching validation, where capital is concentrating and which companies or ideas are beginning to matter.
Over time, the same research architecture can be extended towards more difficult forms of discovery. These include mapping emerging science, identifying private companies and reconstructing the development of technologies and businesses from fragmented evidence.
It can also support more structured analytical tools. Financial models should become living research objects that can be updated automatically and interrogated through natural language, including voice. The analyst should be able to change assumptions, explore scenarios and test conclusions without manually maintaining the underlying spreadsheet.
These tools are intended to support judgement, not conceal it behind a machine. Machines can collect, structure and test evidence. They do not remove the need for someone to decide what it means.
The Briefs are the first product of the system, and the foundation on which the rest can be built.
ALETH / OPEN ACCESS RESEARCH
Much of the information used in capital markets is expensive and exclusive. Many new AI research products preserve this model, using new technology to produce premium-priced tools for the same established customer base.
Aleth takes a different view.
Automation should reduce the cost of producing good research and make broader coverage economically possible. Open access is a deliberate choice made possible by that architecture.
Research that anyone can read improves the information environment for everybody. It can help investors discover unfamiliar companies, give under-researched businesses greater visibility and create a more informed market around scientific and technological innovation.
Aleth’s ambition is to create a trusted public resource and, over time, contribute to better capital allocation and improved market liquidity.
Our work is global, but with a particular interest in the UK. The country has an exceptional scientific base, but has often struggled to convert that strength into scaled, well-understood and liquid technology companies. Better research will not solve that problem by itself. It is, however, part of the necessary infrastructure.
* * *
ALETH / THE NAME
Aleth is the ancient Greek root ἀλήθ: the stem of ἀληθής (alēthḗs), true, and ἀλήθεια (alḗtheia), truth.
The word is associated with the idea of unconcealment: truth as what remains when concealment is stripped away. It is a useful description of research, particularly in markets where the origin and reliability of information are increasingly difficult to establish.
It is also a deliberate name for an AI-native research platform. Generative models are optimised to produce plausible answers. Plausibility is not truth.
Aleth therefore begins with provenance. Research should remain connected to its underlying evidence, with a clear route from any conclusion back to the sources on which it rests.
ἀλήθ
* * *
ἀλήθ (alēth) — the root of ἀλήθεια (alētheia): truth, the unconcealed